ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,916Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 237

$547K Total Retail Price of All Prescriptions

Rank: 34 out of 237

500 Patients Receiving at Least One Drug in Part D
69% Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Maine
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

12% of this provider’s 500 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 500 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Maine
ATORVASTATIN CALCIUM 349 247 74 1 5
OMEPRAZOLE 325 222 72 2 4
LEVOTHYROXINE SODIUM 280 219 50 3 3
AMLODIPINE BESYLATE 277 236 68 4 6
HYDROCODONE-ACETAMINOPHEN 266 159 58 S3 5 12
LISINOPRIL 254 215 68 6 1
WARFARIN SODIUM 204 170 31 7 15
METOPROLOL TARTRATE 197 162 42 8 8
SIMVASTATIN 190 147 56 9 2
FUROSEMIDE 188 168 42 10 7
LOSARTAN POTASSIUM 187 158 38 11 14
OXYCODONE HCL 181 39 28 S2 12 29
ATENOLOL 166 119 48 13 10
HYDROCHLOROTHIAZIDE 142 108 42 14 9
METFORMIN HCL 141 83 34 15 11
TRAMADOL HCL 134 55 39 16 23
PREDNISONE 128 105 53 17 25
METOPROLOL SUCCINATE 120 108 24 18 13
PRAVASTATIN SODIUM 118 62 33 19 19
RANITIDINE HCL 116 67 24 20 36
GLIPIZIDE 113 84 28 21 40
GABAPENTIN 105 35 20 22 17
ALPRAZOLAM 102 24 23 B 23 35
PROAIR HFA 99 50 38 24 33
CRESTOR 96 67 18 25 31
FLUTICASONE PROPIONATE 89 68 26 26 32
LANTUS 87 73 11 27 47
SERTRALINE HCL 86 52 29 28 16
DIAZEPAM 75 31 19 B 29 78
SPIRIVA 75 43 18 29 27
LORAZEPAM 74 19 20 B 31 20
FLUOXETINE HCL 74 42 12 31 54
CLONAZEPAM 73 33 18 B 33 39
PANTOPRAZOLE SODIUM 69 49 16 34 18
DOXAZOSIN MESYLATE 67 53 14 35 62
PROPRANOLOL HCL 62 <11 12 36 115
CYMBALTA 61 <11 <11 37 50
ZOLPIDEM TARTRATE 60 25 20 38 30
ADVAIR DISKUS 55 39 14 39 21
ISOSORBIDE MONONITRATE ER 55 41 11 39 41
CLONIDINE HCL 53 48* 11 41 102
AZITHROMYCIN 52 36 45 42 59
CLOPIDOGREL 51 46* 11 43 43
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 31 19 43 51
TAMSULOSIN HCL 50 45* 13 45 26
ROPINIROLE HCL 50 <11 <11 45 73
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.